Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

Sean Matthews, MSc

Mr.
GSK, Ireland

Disclosure(s): GSK: Advisor/Consultant

Poster(s):

(P-17) Worldwide Impact of Increased Recombinant Zoster Vaccine Coverage on the Burden of Herpes Zoster, based on 11-year Clinical Trial Follow-up Data, in Adults Aged ≥50 Years

Thursday, October 17, 2024
12:15 PM – 1:30 PM US PT
(P-112) Characterization of Herpes Zoster Cases and Sustained High Vaccine Efficacy Against Herpes Zoster Complications in Individuals Vaccinated with Recombinant Zoster Vaccine During A Long-Term Follow-Up Study

Thursday, October 17, 2024
12:15 PM – 1:30 PM US PT